Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A variety of mostly hereditary, structural, or electrical cardiac disorders are associated with SCD in young athletes, the majority of which can be identified or suggested by abnormalities on a resting 12-lead electrocardiogram (ECG). Whether used for diagnostic or screening purposes, physicians responsible for the cardiovascular care of athletes should be knowledgeable and competent in ECG interpretation in athletes. However, in most countries a shortage of physician expertise limits wider application of the ECG in the care of the athlete. A critical need exists for physician education in modern ECG interpretation that distinguishes normal physiological adaptations in athletes from distinctly abnormal findings suggestive of underlying pathology. Since the original 2010 European Society of Cardiology recommendations for ECG interpretation in athletes, ECG standards have evolved quickly over the last decade; pushed by a growing body of scientific data that both tests proposed criteria sets and establishes new evidence to guide refinements. On 26-27 February 2015, an international group of experts in sports cardiology, inherited cardiac disease, and sports medicine convened in Seattle, Washington, to update contemporary standards for ECG interpretation in athletes. The objective of the meeting was to define and revise ECG interpretation standards based on new and emerging research and to develop a clear guide to the proper evaluation of ECG abnormalities in athletes. This statement represents an international consensus for ECG interpretation in athletes and provides expert opinion-based recommendations linking specific ECG abnormalities and the secondary evaluation for conditions associated with SCD.
Introduction
Cardiovascular-related sudden death is the leading cause of mortality in athletes during sport and exercise. [1] [2] [3] The majority of disorders associated with an increased risk of sudden cardiac death (SCD) are suggested or identified by abnormalities on a resting 12-lead ECG.
Whether used for the evaluation of cardiovascular-related symptoms, a family history of inheritable cardiac disease or premature SCD, or for screening of asymptomatic athletes, ECG interpretation is an essential skill for all physicians involved in the cardiovascular care of athletes.
The 2015 summit on ECG interpretation in athletes
Over the last decade, ECG interpretation standards have undergone several modifications to improve the accuracy of detecting potentially life threatening cardiac conditions in young athletes while also limiting false positive results. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] In February 2015, an international group of experts convened in Seattle, Washington, to update contemporary recommendations for ECG interpretation in asymptomatic athletes aged 12-35 years. The goals of the summit meeting were to: (i) update ECG interpretation standards based on new and emerging research and (ii) develop a clear guide to the appropriate evaluation of ECG abnormalities for conditions associated with SCD in athletes.
In the presence of cardiac symptoms or a family history of inherited cardiovascular disease or premature SCD, a normal ECG should not preclude further assessment.
This document provides the most updated evidence-based recommendations developed with thoughtful attention to balance sensitivity and specificity, while maintaining a clear and practical checklist of findings to guide ECG interpretation for physicians and the appropriate evaluation of ECG abnormalities. A summary of the consensus recommendations is presented in Figure 1 , Tables 1 and 2 .
Limitations
While ECG increases the ability to detect underlying cardiovascular conditions associated with SCD, ECG as a diagnostic tool has limitations in both sensitivity and specificity. Specifically, ECG is unable to detect anomalous coronary arteries, premature coronary atherosclerosis, and aortopathies. In some instances patients with cardiomyopathies, particularly arrhythmogenic right ventricular cardiomyopathy (ARVC), may also reveal a normal ECG. Thus, an ECG will not detect all conditions predisposing to SCD. Furthermore, inter-observer variability among physicians remains a major concern, [16] [17] [18] despite studies demonstrating that using standardized criteria improves interpretation accuracy. 19, 20 Normal ECG findings in athletes
Physiological cardiac adaptations to regular exercise
Regular and long-term participation in intensive exercise (minimum of 4 h per week) is associated with unique electrical manifestations 
ECG abnormality Definition
T wave inversion
> _ 1 mm in depth in two or more contiguous leads; excludes leads aVR, III, and V1
• V2-V4
-excludes: black athletes with J-point elevation and convex ST segment elevation followed by TWI in V2-V4; athletes < age 16 with TWI in V1-V3; and biphasic T waves in only V3
• 
Left axis deviation -30 to -90
Left atrial enlargement Prolonged P wave duration of > 120 ms in leads I or II with negative portion of the P wave > _ 1 mm in depth and > _ 40 ms in duration in lead V1
Right axis deviation > 120
Right atrial enlargement P wave > _ 2.5 mm in II, III, or aVF Complete right bundle branch block rSR 0 pattern in lead V1 and a S wave wider than R wave in lead V6 with QRS duration > _ 120 ms
Normal ECG findings in athletes
These training-related ECG alterations are physiologic adaptations to regular exercise, considered normal variants in athletes, and do not require further evaluation in asymptomatic athletes with no significant family history. that reflect enlarged cardiac chamber size and increased vagal tone. These ECG findings in athletes are considered normal, physiological adaptations to regular exercise and do not require further evaluation ( Figure 1 ; Table 1 ).
Normal ECG finding Definition

Left and right ventricular hypertrophy
The presence of isolated QRS voltage criterion for left ventricular hypertrophy (LVH) ( Figure 2 ) does not correlate with pathology in athletes and is present in isolation (without other associated ECG abnormalities) in less than 2% of patients with hypertrophic cardiomyopathy (HCM). [21] [22] [23] [24] [25] [26] [27] Conversely, pathological LVH is commonly associated with additional ECG features such as T-wave inversion (TWI) in the inferior and lateral leads, ST segment depression, and pathological Q waves. 28, 29 
Early repolarization
Early repolarization is defined as elevation of the QRS-ST junction (Jpoint) by > _ 0.1 mV often associated with a late QRS slurring or notching (J wave) affecting the inferior and/or lateral leads. [32] [33] [34] Early repolarization is common in healthy populations (2-44%) and is more prevalent in athletes, young individuals, males, and black ethnicity. 32, [35] [36] [37] [38] [39] Early repolarization consisting of J-point elevation with concave ST-segment elevation and a peaked TWI (Figure 2 ) is present in up to 45% of Caucasian athletes and 63-91% of black athletes of African-Caribbean descent (hereto referred to as 'black' athletes). 22, 30 Some studies on survivors of cardiac arrest and patients with primary ventricular fibrillation (VF) have suggested an association between early repolarization and the risk of VF. 33, 40 Although further studies are warranted to fully elucidate the mechanisms and prognostic implications of early repolarization in competitive athletes, to date there are no data to support an association between inferior early repolarization and SCD in athletes. Based on current evidence, all patterns of early repolarization, when present in isolation and without clinical markers of pathology, should be considered benign variants in athletes. 41 
Repolarization findings in black athletes
Ethnicity is a major determinant of cardiac adaptation to exercise with more than two-thirds of black athletes exhibiting repolarization changes. 29, 30, 42, 43 Black athletes also commonly demonstrate a repolarization variant consisting of J-point elevation and convex ST segment elevation in the anterior leads (V1-V4) followed by TWI ( Figure 3 and Figure 4B and C) which is regarded as a normal variant and should not result in further investigation, in the absence of other clinical or ECG features of cardiomyopathy. The QT interval corrected for heart rate is ideally measured using Bazett's formula with heart rates between 60 and 90 bpm; preferably performed manually in lead II or V5 using the teach-the-tangent method 1 to avoid inclusion of a U wave (please see text for more details). Consider repeating the ECG after mild aerobic activity for a heart rate-< 50 bpm, or repeating the ECG after a longer resting period for a heart rate > 100 bpm, if the QTc value is borderline or abnormal. International recommendations for electrocardiographic interpretation ('domed') ST segment elevation followed by T-wave inversion in V1-V4 (circles). This is a normal repolarization pattern in black athletes. 
Physiological arrhythmias in athletes
Common consequences of increased vagal tone include sinus bradycardia and sinus arrhythmia. 22, [47] [48] [49] Other, less common markers of increased vagal tone are junctional or ectopic atrial rhythms, first degree atrioventricular (AV) block, and Mobitz Type I second degree AV block (Wenckebach phenomenon). 22, 47, 50 In the absence of symptoms, heart rates > _ 30 bpm are considered normal in highly trained athletes. Sinus rhythm should resume and bradycardia should resolve with the onset of physical activity.
Borderline electrocardiogram findings in athletes
Recent data suggest that some ECG findings previously categorized as abnormal may represent normal variants or the result of physiological cardiac remodelling in athletes and do not usually represent International recommendations for electrocardiographic interpretation pathological cardiac disease. These ECG findings have been categorized as 'borderline' findings in athletes ( Figure 1 ; Table 1 ).
Axis deviation and voltage criteria for atrial enlargement
Axis deviation and voltage criteria for atrial enlargement account for-> 40% of abnormal ECG patterns in athletes but do not correlate with cardiac pathology. 51 In a large study of 2533 athletes aged years old and 9997 controls of similar age, echocardiographic evaluation of the 579 athletes and controls with isolated axis deviation or voltage criteria for atrial enlargement failed to identify any major structural or functional abnormalities. 51 Complete right bundle branch block
Although incomplete right bundle branch block (RBBB) is common in young athletes, the significance of complete RBBB is less certain.
Complete RBBB is detected in approximately 1% of the general population and large datasets in young adult athletes reveal a prevalence of 0.5-2.5%. 12, [52] [53] [54] In a study of 510 U.S. collegiate athletes, RBBB was reported in 2.5% and compared with athletes with normal QRS complexes or incomplete RBBB, athletes with complete RBBB exhibited larger right ventricular dimensions and a lower right ventricular ejection fraction but preserved fractional area change. 55 None of the athletes with complete RBBB or incomplete RBBB was found to have pathological structural cardiac disease. These patterns among trained athletes could represent a spectrum of structural and physiological cardiac remodelling characterized by RV dilation with resultant QRS prolongation and a relative reduction in the RV systolic function at rest. 55 Based on the aforementioned considerations, left axis deviation, left atrial enlargement, right axis deviation and right atrial enlargement and complete RBBB are considered borderline variants in athletes. The presence of any one of these findings in isolation or with other recognized physiological electrical patterns of athletic training does not warrant further assessment in asymptomatic athletes without a family history of premature cardiac disease or SCD. Conversely, the presence of more than one of these borderline findings places the athlete in the abnormal category warranting additional investigation.
Abnormal electrocardiogram findings in athletes
The abnormal findings defined in this section are not recognized features of athletic training and always require further assessment to exclude the presence of intrinsic cardiac disease (Figure 1 ; Tables 1  and 2) . Temporary restriction from athletic activity should be considered for athletes with abnormal ECGs of uncertain clinical significance until secondary investigations are completed.
Abnormal T-wave inversion
TWI > _ 1 mm in depth in two or more contiguous leads (excluding leads aVR, III, and V1) in an anterior, lateral, inferolateral, or inferior territory is abnormal and should prompt further evaluation for underlying structural heart disease ( Tables 1 and 2) . Normal exceptions include TWI confined to leads V1-V4 in black athletes when preceded by J point and/or ST segment elevation, and TWI in leads V1-V3 in athletes aged < 16 years.
Clinical considerations
The relationship between abnormal TWI and several forms of structural heart disease is well documented. 56 TWI in the inferior or lateral leads is common in HCM. [56] [57] [58] [59] Whereas TWI in the right precordial leads (V1-V3) or beyond in the absence of a complete RBBB is common in ARVC ( Figure 4D ).
60,61
There are no data relating to the significance of flat or biphasic T waves in athletes but similar to TWI, this panel would recommend further evaluation of biphasic T waves where the negative portion is > _ 1 mm in depth in > _ 2 leads.
Evaluation
Lateral or inferolateral T-wave inversion
There is mounting evidence that TWI in the lateral or inferolateral leads is associated with the presence of quiescent cardiomyopathy in a considerable proportion of athletes. 30, [62] [63] [64] Recommendations for the evaluation of abnormal TWI and other clinical considerations are presented in Table 2 . TWI affecting the lateral leads (V5-V6, I and aVL) ( Figure 4E ) should prompt a comprehensive investigation to exclude cardiomyopathy. If echocardiography is not diagnostic, cardiac magnetic resonance imaging (MRI) with gadolinium should be utilized. Cardiac MRI provides superior assessment of myocardial hypertrophy, especially the left ventricular apex and the lateral free wall and may also demonstrate late gadolinium enhancement (LGE), a non-specific marker suggesting myocardial fibrosis. If cardiac MRI is not available, echocardiography with contrast should be considered. Exercise ECG testing and Holter monitoring also should be considered in the evaluation of lateral or inferolateral TWI, especially for athletes with 'grey zone' hypertrophy (males with maximal LV wall thickness 13-16 mm) without LGE, where the diagnosis of HCM remains uncertain. In such cases, the presence of ventricular tachycardia during exercise or Holter may support HCM and is also useful in risk stratification. 65 For athletes with lateral or inferolateral TWI, regular follow-up with serial cardiac imaging is necessary even when the initial evaluation is normal, in order to monitor for the development of a cardiomyopathy phenotype.
62,63
Anterior T-wave inversion Anterior TWI is a normal variant in asymptomatic adolescent athletes age < 16 years, in black athletes when preceded by J-point elevation and convex ST segment elevation, and in some endurance athletes. 66, 67 However, anterior TWI in leads V1-V2/V3 also is a recognized pattern in patients with ARVC and rarely HCM. There are discrepancies among existing guidelines relating to the extent of anterior TWI inversion before considering further investigations. 5, 6, 14, 29 A large study of over 14 000 white adults aged 16-35 years old, including over 2500 athletes showed that anterior TWI had a prevalence of 2.3%. 68 Anterior TWI was more common in females and athletes and was confined to leads V1-V2 in almost all individuals, and only exceeded beyond V2 in 1% of females and 0.2% of males. 68 None of the individuals with anterior TWI were diagnosed with a cardiomyopathy following comprehensive investigation indicating that this particular ECG pattern is non-specific in low-risk populations. Specific information about the J-point and preceding ST segment may help differentiate between physiological adaptation and cardiomyopathy in athletes with anterior TWI affecting leads V3 and/or V4. A recent study comparing anterior TWI in a series of black and white healthy athletes, and patients with HCM and ARVC, showed that in athletes with anterior TWI, the combination of J-point elevation > _ 1 mm and TWI confined to leads V1-V4 excluded either cardiomyopathy with 100% negative predictive value, regardless of ethnicity. 66 Conversely, anterior TWI associated with minimal or absent J-point elevation (< 1 mm) could reflect a cardiomyopathy. 66 These data require duplication in larger studies but may prove useful in the assessment of a small proportion of white endurance athletes who exhibit anterior TWI and in athletes of black/mixed ethnicity. 69 In most non-black athletes age > _ 16 years, anterior TWI beyond lead V2 should prompt further evaluation given the potential overlap with ARVC. In these athletes, concurrent findings of J-point elevation, ST segment elevation, or biphasic T waves more likely represents athlete's heart, while the absence of J-point elevation or a coexistent depressed ST segment is more concerning for ARVC ( Figure 5) . 66 Other ECG findings suggestive of ARVC include low limb lead voltages, prolonged S wave upstroke, ventricular ectopy with LBBB morphology, and epsilon waves. 61 A combination of tests is needed to diagnose ARVC including echocardiography, cardiac MRI, Holter monitoring, exercise ECG test, and signal averaged ECG.
Inferior T-wave inversion
The significance of TWI confined to the inferior leads is unknown. However, this finding cannot be attributed to physiological remodelling and thus warrants further investigation with, at minimum, an echocardiogram. Cardiac MRI should be considered based on the echocardiographic findings or clinical suspicion.
ST segment depression
While ST segment depression is common among patients with cardiomyopathy, it is not a feature of athletic training. 28, 59, 70, 71 ST segment depression (relative to the isoelectric PR segment) in excess of 0.05 mV (0.5 mm) in two or more leads should be considered an abnormal finding requiring definitive evaluation for underlying structural heart disease.
Evaluation
Echocardiography is the minimum evaluation for athletes with ST segment depression to investigate for underlying cardiomyopathy. Cardiac MRI should be considered based on the echocardiographic findings or clinical suspicion.
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Figure 5 Examples of physiological (A) and pathological T-wave inversion (B). Panel A demonstrates T-wave inversion in V1-V4 preceded by
J-point elevations and convex 'domed' ST segment elevation (green circles). This should not be confused with pathological T-wave inversion (Panel B) which demonstrates T-wave inversion in V1-V6 with absent J-point elevation and a downsloping ST segment (red circles).
International recommendations for electrocardiographic interpretation
Pathological Q waves
Several pathological disorders including HCM, ARVC, infiltrative myocardial diseases, accessory pathways and transmural myocardial infarction can lead to the development of exaggerated (deep or wide) Q waves or unexpected Q waves in atypical leads. 28, 56 Pathological Q waves also may be a result of lead misplacement. In particular, a pseudo-septal infarct pattern with pathological Q waves in leads V1-V2 is commonly due to high-lead placement relative to cardiac position. 72 Pathological Q waves have been reported in approximately 1-2% of all athletes, and may be higher in males and black athletes. 29, 73 For asymptomatic athletes, pathological Q waves were previously defined as > 3 mm in depth or > 40 ms in duration in two or more leads (except III and aVR). 6, 10 In practice, however, this criterion is a common source of false positive ECG results as trained athletes with physiological LVH and thin adolescent athletes may have increased precordial voltages and deep lateral or inferior Q waves. The use of a Q/R ratio overcomes some of these issues by normalizing Q wave depth to the degree of proceeding R wave voltage. Case control analyses of athletes and HCM patients suggest that this will decrease the false positive rate without compromising sensitivity for the detection of cardiomyopathy. 29, 74 Thus, this consensus panel has modified the definition for pathological Q waves in athletes as a Q/R ratio > _ 0.25 or > _ 40 ms in duration in two or more contiguous leads (except III and aVR).
Evaluation
An ECG with abnormal Q waves should be carefully examined for the possibility of an accessory pathway. If the pathological Q waves are isolated to leads V1-V2, the ECG should be repeated, including re-placing the ECG leads to ensure proper positioning. Persistence of pathological Q waves in two or more contiguous leads warrants further investigation with echocardiography to exclude cardiomyopathy. If the echocardiogram is normal and there are no other concerning clinical findings or ECG abnormalities, no additional testing is generally necessary. However, if there is a high index of clinical suspicion, additional evaluation with cardiac MRI should be considered. In athlete's age > _ 30 years with suspicion of prior myocardial infarction or risk factors for coronary artery disease (CAD), stress testing may be warranted.
Complete left bundle branch block
LBBB is found in less than 1 in 1000 athletes but is common in patients with cardiomyopathy and ischaemic heart disease. 9, 28, 59, 75, 76 Thus, complete LBBB always should be considered an abnormal finding and requires a comprehensive evaluation to rule out a pathological cardiac disorder.
Evaluation
Athletes with complete LBBB require a thorough investigation for myocardial disease including echocardiography and a cardiac MRI with perfusion study.
Profound non-specific intra-ventricular conduction delay
Epidemiological studies of nonspecific intra-ventricular conduction delay (IVCD) in the general population have shown an increased risk of cardiovascular death and have been documented among patients with cardiomyopathy. 77, 78 The significance of non-specific IVCD with normal QRS morphology in healthy, asymptomatic athletes is uncertain. 79 The physiology underlying IVCD in athletes remains incompletely understood but likely includes some combination of neurally mediated conduction fibre slowing and increased myocardial mass. In patients with LVH, left ventricular mass seems to be closely related to QRS duration. 80 While the exact cut-off to trigger more investigation in athletes with a nonspecific IVCD remains unclear, this panel recommends that marked nonspecific IVCD > _ 140 ms in athletes, regardless of QRS morphology, is abnormal and should prompt further evaluation.
Evaluation
In asymptomatic athletes with profound non-specific IVCD, an echocardiogram is recommended to evaluate for myocardial disease. Other testing may be indicated depending on echocardiographic findings or clinical suspicion.
Ventricular pre-excitation
Ventricular pre-excitation occurs when an accessory pathway bypasses the AV node resulting in abnormal conduction to the ventricle (pre-excitation) with shortening of the PR interval and widening of the QRS. This is evident on the ECG as the Wolf-ParkinsonWhite (WPW) pattern defined as a PR interval < 120 ms, the presence of a delta wave (slurring of the initial QRS), and a QRS duration > 120 ms. 81 The WPW pattern occurs in up to 1 in 250 athletes. 9, 12, 52, 82 The presence of an accessory pathway can predispose an athlete to sudden death because rapid conduction of atrial fibrillation across the accessory pathway can result in VF.
Evaluation
A short PR interval in isolation without a widened QRS or delta wave in an asymptomatic athlete should not be considered for further assessment. The WPW pattern warrants further assessment of the refractory period of the accessory pathway. Non-invasive risk stratification begins with an exercise stress test, where abrupt, complete loss of pre-excitation at higher heart rates suggests a low-risk accessory pathway. 83, 84 An echocardiogram also should be considered due to the association of WPW with Ebstein's anomaly and cardiomyopathy. Intermittent pre-excitation during sinus rhythm on a resting ECG is also consistent with a low-risk pathway and may obviate the need for an exercise test. 85 If non-invasive testing cannot confirm a low-risk pathway or is inconclusive, an electrophysiological study should be considered to determine the shortest pre-excited RR interval during atrial fibrillation. 83 If the shortest pre-excited RR interval is < _ 250 ms (240 bpm), then the accessory pathway is deemed high risk and transcatheter ablation is recommended. 83, 86 Some physicians may choose to subject all competitive athletes involved in moderate or high-intensity sport to electrophysiological studies irrespective of the results of the exercise test or 24 h ECG on the premise that high catecholamine concentrations during very intensive exercise may modify the refractory period of an accessory pathway in a fashion that cannot be reproduced during laboratory tests.
Prolonged QT interval
Congenital Long QT syndrome (LQTS) is a potentially lethal, genetically mediated ventricular arrhythmia syndrome with the hallmark 
91-94
Calculating the corrected QT interval Accurate measurement and manual confirmation of the computer derived QT interval corrected for heart rate (QTc) is critical as the accuracy of computer generated QTc values is about 90-95%. Studies have suggested the ability of cardiologists to accurately measure the QTc is suboptimal. 95 However, accurate assessment of the QTc can be achieved by adhering to the following six principles: 96 (1) Use Bazett's heart rate correction formula (QTc = QT/ͱRR; note the RR interval is measured in seconds) as population-based QTc distributions most frequently use Bazett-derived QTc values. 97 (2) Bazett's formula underestimates the QTc at heart rates < 50 bpm, and overestimates the QTc at heart rates > 90 bpm. Accordingly, for a heart rate < 50 bpm, a repeat ECG after mild aerobic activity is recommended to achieve a heart rate closer to 60 bpm. For heart rates > 90 bpm, a repeat ECG after additional resting time may help achieve a lower heart rate. (3) If sinus arrhythmia is present with beat to beat variation in heart rate, an average QT interval and average RR interval should be used. (4) Leads II and V5 usually provide the best delineation of the T wave.
(5) Low amplitude U waves, which are common in the anterior precordial leads, should not be included in the QT calculation. The 'Teachthe-Tangent' or 'Avoid-the-Tail' method to delineate the end of the T wave should be followed ( Figure 6 ).
96
(6) The morphology of the T wave, not just the length of the QT interval, also can suggest the presence of LQTS. 98 For instance, a notched T wave in the lateral precordial leads where the amplitude of the second portion of the T wave following the notch is greater than the first portion of the T wave may represent LQT-2 even in the absence of overt QT prolongation.
The easiest and most efficient way to confirm the computerderived QTc is to examine lead II and/or V5 and determine if the manually measured QT interval matches the computer's QT measurement. If there is concordance within about 10 ms, one can trust that the computer can derive accurately an average RR interval and complete the Bazett's calculation. If, however, the manually measured QT interval is > 10 ms different than the computer's QT measurement, an average RR interval should be determined and the QTc recalculated using the Bazett's formula.
Corrected QT cut-offs
Given the overlap between QTc distributions in population-derived cohorts of healthy individuals compared with patients with genetically confirmed LQTS, the QTc cut-off value compelling further evaluation must be chosen carefully to balance the frequency of abnormal results and the positive predictive value for LQTS.
Recent consensus statements on ECG interpretation in athletes have recommended that male athletes with a QTc > _ 470 ms and International recommendations for electrocardiographic interpretation female athletes with a QTc > _ 480 ms undergo further evaluation for LQTS to better balance false positive and false negative findings. 6, 10 These cut-off values are around the 99th percentile and consistent with thresholds defined by the American Heart Association and American College of Cardiology. 99 This consensus group also recommends QTc values of > _ 470 ms in males and > _ 480 ms in females to define the threshold of QT prolongation that warrants further assessment in asymptomatic athletes.
Short QT Interval
The precise cut-off and clinical significance of a short QT interval in athletes is unknown. Data from over 18 000 asymptomatic young British individuals found that the prevalence of a QTc < 320 ms is 0.1%; suggesting an abnormal cut-off value of < 320 ms is pragmatic. 100 However, over a mean follow up period of 5.3 years, none of the individuals with a short QT < 320 ms experienced any adverse events, syncope, or sudden death. 100 Based on the rarity of this finding and absence of data to suggest long-term morbidity in asymptomatic athletes, this panel recommends that a short QT interval only be investigated in the context of concerning clinical markers.
Evaluation
It is critical that an athlete with a single prolonged QTc reading not be obligated a diagnosis of LQTS, but rather that these cut-off values trigger the need for additional evaluation. The importance of additional evaluation but not a premature diagnosis of LQTS was demonstrated in a study of 2000 elite athletes in which 7 (0.4%) had a prolonged QTc (range 460-570 ms). 101 A QTc of < 500 ms in the absence of symptoms or familial disease was unlikely to represent LQTS. In contrast, a QTc > _ 500 ms was highly suggestive of LQTS as all three athletes with a QTc value of > 500 ms exhibited one of paradoxical prolongation of the QTc during exercise, a confirmatory genetic mutation, or prolonged QTc in a first-degree relative. 101 A personal history of syncope or seizures and a family history of exertional syncope, 'epilepsy', postpartum-timed syncope/seizure, unexplained motor vehicle accidents, unexplained drowning, and premature, unexplained sudden death < 50 years of age should be reviewed. If the personal/family history is positive, the athlete should be referred to an electrophysiologist for further evaluation. If the personal/family history is negative, a repeat ECG should be obtained (ideally on a different day). If the follow-up ECG is below the QTc cut-off values, then no additional evaluation is needed and the athlete should be reassured.
If the repeat ECG still exceeds the QTc cut-off values, then a screening ECG of the athlete's first degree relatives (parents and siblings) should be considered and the athlete should be referred to an electrophysiologist for the possibility of newly discovered LQTS. Reversible, extrinsic factors, such as electrolyte abnormalities (hypokalaemia) or the presence of QT prolonging medications, must also be evaluated. If an athlete's ECG shows a QTc > _ 500 ms and no reversible causes are identified, then the athlete should be referred immediately to an electrophysiologist as the probability of LQTS and future adverse events has increased. 102 The Schwartz-Moss scoring system, electrocardiographic features, stress ECG, provocative testing, and genetic testing may be needed to clarify the diagnosis and should be performed and interpreted by a cardiologist familiar with the disease.
103-106
Brugada Type 1 pattern
Brugada syndrome (BrS) is an inherited primary electrical disease which predisposes to ventricular tachyarrhythmias and sudden death during states of enhanced vagal tone. It is characterized by the distinctive Brugada ECG pattern which consists of a coved rSr' pattern, STsegment elevation > _ 2 mm, and inversion of the terminal portion of the T wave in leads V1, V2, and V3 ( Figure 4F) . Although three types were described, only the Type 1 Brugada pattern is now considered diagnostic.
107-109
The coved ST segment elevation in Type 1 Brugada pattern results in a broad r' and should be distinguishable from the upsloping ST segment elevation of early repolarization in an athlete. In this regard, the 'Corrado index' measures the ST elevation at the start of the ST segment/J-point (STJ) and 80 ms after the start of the ST segment (ST80). 110 In Type 1 Brugada pattern, the downsloping ST segment will have a STJ/ST80 ratio > 1, while the initial upsloping of the ST segment found in early repolarization patterns in an athlete will produce an STJ/ST80 ratio < 1 ( Figure 7 ).
Evaluation
The Type 1 Brugada ECG pattern should be investigated regardless of symptoms. If the pattern is unclear, confirm correct lead placement, repeat the ECG if necessary, and perform a high precordial lead ECG with V1 and V2 placed in the 2nd or 3rd intercostal space. If the Type 1 pattern is seen on a high-precordial lead ECG, then referral to an electrophysiologist is indicated. Consideration should be given to potential accentuating factors for a Brugada-like ECG pattern, such as hyperkalaemia, fever, medications with sodium ion channel blocking properties, and lead placement.
Profound sinus bradycardia or first degree atrioventricular block
Sinus bradycardia and moderate prolongation of the PR interval (200-399 ms) are recognized features of athletic conditioning. Although a resting heart rate < _ 30 bpm or a PR interval > _ 400 ms may be normal in a well-trained athlete, it should prompt further evaluation for cardiac conduction disease.
Evaluation
Evaluation of profound sinus bradycardia or a markedly increased PR interval should include assessing the chronotropic response to mild aerobic activity, such as running on the spot or climbing stairs. Exercise testing is useful in this situation to provide an objective measure of the PR interval and heart rate response to aerobic activity. If the heart rate increases appropriately and the PR interval normalizes, and the athlete is asymptomatic, no further testing is necessary. Conversely, further evaluation should be performed if the heart rate does not increase or the PR interval does not shorten appropriately on exertion, the athlete experiences pre-syncope/ syncope, or in athletes with a family history of cardiac disease or sudden death. Depending on the clinical scenario, an echocardiogram or ambulatory ECG monitor may be indicated. 
High grade atrioventricular block
Multiple premature ventricular contractions
Multiple (> _ 2) premature ventricular contractions (PVCs) are uncommon and present in < 1% of 12-lead ECGs in athletes. 9, 12 Although multiple PVCs are usually benign, their presence may be the hallmark of underlying heart disease. 111, 112 PVCs originating from the right ventricular outflow tract (LBBB and inferior axis origin) are considered particularly benign when associated with a normal ECG, however this PVC morphology can also be present in patients with early ARVC particularly when the QRS exceeds 160 ms. 113 Therefore, the finding of > _ 2 PVCs on an ECG should prompt more extensive evaluation to exclude underlying structural heart disease.
Evaluation
The extent of evaluation for > _ 2 PVCs is controversial and excluding pathology may be difficult. At a minimum, an ambulatory Holter monitor, echocardiogram, and exercise stress test should be performed. 
Atrial tachyarrhythmias
Sinus tachycardia is the most common atrial tachyarrhythmia but is very rarely due to intrinsic cardiac disease. Supraventricular tachycardia (SVT), atrial fibrillation, and atrial flutter are rarely seen on a resting ECG in athletes and require investigation. Atrial tachyarrhythmias are rarely life threatening but can be associated with other conditions that can lead to SCD, including LQTS, WPW, BrS, myocarditis, congenital heart disease, and the cardiomyopathies.
Evaluation
If resting sinus tachycardia > 120 bpm is seen, a repeat ECG should be considered after a period of rest as recent exercise or anxiety may be the cause. Other underlying aetiologies may be sought, including fever, infection, dehydration, stimulant use, anaemia, hyperthyroidism, or, rarely, underlying cardiac or pulmonary disease. International recommendations for electrocardiographic interpretation or the diving reflex is used to terminate the arrhythmia, a rhythm strip should be obtained which can help elucidate the mechanism of the SVT. An echocardiogram, ambulatory ECG monitor, and exercise treadmill test should be completed. Referral to an electrophysiologist may be indicated for consideration of electrophysiology study and ablation.
If atrial fibrillation or flutter is found, an echocardiogram should be completed to assess for structural heart disease and anti-coagulation considered based on standard guidelines. 119 An ambulatory ECG monitor should be used to assess if the rhythm is paroxysmal or persistent and what the ventricular rate is throughout the day. A thorough family history may elucidate an underlying genetic cause. Depending on what these results show, cardiac MRI, electrophysiology study with possible ablation, and/or genetic testing may be considered.
Ventricular arrhythmias
Ventricular couplets, triplets, and non-sustained ventricular tachycardia always require investigation as they can be a marker for underlying cardiac pathology or lead to sustained ventricular tachycardia which may cause SCD.
Evaluation
If ventricular arrhythmias are seen, the evaluation should include a thorough family history, an echocardiogram to evaluate for structural heart disease, cardiac MRI to assess for ARVC or other cardiomyopathies, ambulatory ECG monitor and exercise ECG test. Depending on these results, further evaluation may be needed including electrophysiology study or genetic testing.
Considerations in athletes 30 years of age
In athletes > _ 30 years of age, CAD is the most common cause of SCD. 89, 90 In addition, older athletes may be less fit compared with 20-30 years ago, increasing the possibility of underlying CAD. 120, 121 While resting ECGs have a low sensitivity for CAD, some ECG patterns may suggest underlying CAD such as TWI, pathological Q waves, ST segment depression, left or RBBB, abnormal R wave progression, left anterior hemiblock, and atrial fibrillation.
122-124
Evaluation
The main role of a resting ECG in older athletes is to identify those athletes who may potentially be at high risk for CAD and warrant further testing. 123, 125, 126 Initial testing should include an exercise stress test, resting echocardiogram, and assessment of traditional risk factors for CAD. When indicated, this evaluation may be complemented by coronary CT angiography or a functional stress test.
Electrocardiogram patterns requiring serial evaluation
Several common heritable cardiomyopathies may present with ECG abnormalities prior to the onset of overt heart muscle pathology. 62, 63 Therefore, athletes with abnormal ECGs suggestive of cardiomyopathy and initially normal clinical evaluations should be followed with serial evaluation during and after their competitive athletic careers. Evaluations may be conducted annually or more frequently depending on individual circumstances. These athletes may be permitted to participate in competitive athletics without restriction contingent on longitudinal follow-up.
Conclusion
Accurate ECG interpretation in athletes requires adequate training and an attention to detail to distinguish physiological ECG findings from abnormal ECG findings that might indicate the presence of cardiac pathology. The international consensus standards presented on ECG interpretation and the evaluation of ECG abnormalities serve as an important foundation for improving the quality of cardiovascular care of athletes. As new scientific data become available, revision of these recommendations may be necessary to further advance the accuracy of ECG interpretation in the athletic population.
Supplementary material
Supplementary material is available at European Heart Journal online.
